Synthesis of pyrrole-fused dibenzoxazepine/dibenzothiazepine/triazolobenzodiazepine derivatives via isocyanide-based multicomponent reactions

• Marzieh Norouzi,
• Mohammad Taghi Nazeri,
• Ahmad Shaabani and
• Behrouz Notash

Beilstein J. Org. Chem. 2024, 20, 2870–2882, doi:10.3762/bjoc.20.241

• .20.241 Abstract An efficient and facile synthesis of pyrrole-fused dibenzoxazepine/dibenzothiazepine/triazolobenzodiazepine derivatives was developed through the isocyanide-based multicomponent reaction of isocyanides, gem-diactivated olefins, and cyclic imines such as dibenzoxazepine, dibenzothiazepine

• , and triazolobenzodiazepine under solvent- and catalyst-free conditions. Purposefully, this approach produced various bioactive scaffolds using environmentally friendly, mild, and simple conditions. Due to their bioactive moieties, these compounds with exclusive fluorescence properties may attract

• great attention in biomedical applications, clinical diagnostics, and conjugate materials. Keywords: cyclic imines; dibenzothiazepine; dibenzoxazepine; isocyanides; multicomponent reactions; pyrrole; triazolobenzodiazepine; Introduction Pyrroles and their derivatives are important N-heterocyclic

Decarboxylative 1,3-dipolar cycloaddition of amino acids for the synthesis of heterocyclic compounds

• Xiaofeng Zhang,
• Xiaoming Ma and
• Wei Zhang

Beilstein J. Org. Chem. 2023, 19, 1677–1693, doi:10.3762/bjoc.19.123

• under the catalysis of AcOH at 110 °C for 6 h afforded the monocycloaddition product 19a in 93% LC yield [71]. The isolated compound 19a was used for an N-propargylation to produce compound 20a in 94% LC yield. The following Cu-catalyzed click reaction afforded triazolobenzodiazepine 21a in 88% LC yield

• bioactive heterocyclic compounds in medicinal and drug discovery programs. Classification of AMYs. Biologically interesting pyrrolizidines. Biologically interesting spirooxindole-pyrrolizidines. Bioactive triazolobenzodiazepine derivatives. Bioactive pyrroloquinazolines and pyrrolobenzodiazepines. Bioactive

• diastereoselective synthesis of bis[spirooxindole-pyrrolizidine]s. Stepwise synthesis of triazolobenzodiazepine 21a. One-pot synthesis of triazolobenzodiazepines. One-pot synthesis of tetrahydropyrroloquinazolines. One-pot synthesis of tetrahydropyrrolobenzodiazepines. Stepwise synthesis of pyrrolo[2,1-a

Effective microwave-assisted approach to 1,2,3-triazolobenzodiazepinones via tandem Ugi reaction/catalyst-free intramolecular azide–alkyne cycloaddition

• Maryna O. Mazur,
• Oleksii S. Zhelavskyi,
• Eugene M. Zviagin,
• Svitlana V. Shishkina,
• Vladimir I. Musatov,
• Maksim A. Kolosov,
• Elena H. Shvets,
• Anna Yu. Andryushchenko and
• Valentyn A. Chebanov

Beilstein J. Org. Chem. 2021, 17, 678–687, doi:10.3762/bjoc.17.57

• success in the treatment of CNS disorders [6]. Preliminary studies of the biological activity of other diversely substituted 1,2,3-triazolobenzodiazepines demonstrate their similar properties with all main categories of 1,2,4-triazolobenzodiazepine-based drugs [7]. For example, compound B demonstrated

Sequential Ugi reaction/base-induced ring closing/IAAC protocol toward triazolobenzodiazepine-fused diketopiperazines and hydantoins

• Robby Vroemans,
• Fante Bamba,
• Jonas Winters,
• Joice Thomas,
• Jeroen Jacobs,
• Luc Van Meervelt,
• Jubi John and
• Wim Dehaen

Beilstein J. Org. Chem. 2018, 14, 626–633, doi:10.3762/bjoc.14.49

• (CSIR-NIIST), Thiruvananthapuram-19, India 10.3762/bjoc.14.49 Abstract A practical three-step protocol for the assembly of triazolobenzodiazepine-fused diketopiperazines and hydantoins has been developed. The synthesis of these tetracyclic ring systems was initiated by an Ugi reaction, which brought

• ) and two ring-closing steps toward triazolobenzodiazepine-fused diketopiperazines and hydantoins. Benzodiazepine derivatives [24][25] form an important class of ‘psychoactive drugs’ which is being extensively used in the treatment of anxiety, insomnia, agitation, seizures, muscle spasms, alcohol

• -turns [43][44][45] and are also known to bind to a number of biological targets [46][47][48]. Interestingly, the fusion of a triazole ring to a 1,4-benzodiazepine core has resulted in an increase in the biological activity as evident from the different drugs with triazolobenzodiazepine structure such as